ARCHIVES

Executive Summary of Centers, SPOREs Report

This article is from The Cancer Letter archive.

Vol. 29 No. 09 | February 28, 2003

Download PDF Visit The Full Archive

Related Articles

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

Cancer Policy: Board Advocates $2 Per Pack Raise For Cigarettes

January 16, 1998

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003